PRMT5 catalyzes the vast majority of SDMA posttranslational modifications on histones (12), splicing factors (13), transcription factors and enhancer-binding proteins (14, 15), metabolic enzymes, and cell signaling proteins (16, 17, 18) implicating its role in cancer progression and survival. The gene discussed is PRMT5; the disease is cancer.